Apyx Medical Corp - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
APYX Nasdaq 3841 https://apyxmedical.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apyx Medical Corp

Is Apyx Medical (APYX) Stock Outpacing Its Medical Peers This Year? - May 16th, 2023 1:40 pm
Q1 2023 Apyx Medical Corp Earnings Call - May 12th, 2023 3:42 am
Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook - May 11th, 2023 11:00 am
Investors Aren't Entirely Convinced By Apyx Medical Corporation's (NASDAQ:APYX) Revenues - May 5th, 2023 5:31 pm
RENUVION® RECEIVES FDA CLEARANCE FOR SPECIFIC USE AFTER LIPOSUCTION - May 2nd, 2023 11:30 am
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring - Apr 28th, 2023 11:30 am
The past year for Apyx Medical (NASDAQ:APYX) investors has not been profitable - Apr 14th, 2023 2:28 pm
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023 - Apr 5th, 2023 8:05 pm
Renuvion Wins ADDY® Award for #ThisIsMe Campaign - Mar 27th, 2023 10:55 am
Apyx Medical Corporation (NASDAQ:APYX) Q4 2022 Earnings Call Transcript - Mar 18th, 2023 6:03 am
Q4 2022 Apyx Medical Corp Earnings Call - Mar 17th, 2023 4:27 am
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook - Mar 16th, 2023 11:00 am
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed - Feb 27th, 2023 12:30 pm
Apyx Medical Corporation (NASDAQ:APYX) insider upped their holding by 42% earlier this year - Feb 23rd, 2023 12:47 pm
Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial - Feb 21st, 2023 12:30 pm
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023 - Feb 16th, 2023 12:30 pm
RENUVION® COSMETIC NECK LAXITY PROCEDURE TO BE FEATURED ON 'THE BALANCING ACT' TALK SHOW ON LIFETIME® FEBRUARY 13 - Feb 9th, 2023 12:30 pm
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction - Feb 1st, 2023 12:30 pm
Recent uptick might appease Apyx Medical Corporation (NASDAQ:APYX) institutional owners after losing 72% over the past year - Jan 27th, 2023 10:41 am
APYX MEDICAL CORPORATION LAUNCHES NEW 'APYX ONE CONSOLE' FOR COSMETIC SURGICAL PROCEDURES IN THE UNITED STATES - Jan 25th, 2023 12:30 pm